{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:52:45Z","timestamp":1793652765057,"version":"4.5.1"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>British Association of Dermatologists (BAD) guidelines for managing basal (BCC) and squamous (SCC) cell skin carcinomas are distinct; however, there is a paucity of evidence relating to the histopathological behaviour of SCC and BCC over time, and the implications this has for management guidelines.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To investigate the effect of lesion duration on keratinocyte skin cancer (KSC) growth, the development of high risk factors and excision margin adequacy; further aims included investigating the impact of the presence of high or very high risk histological parameters on excision rates and clearance margins.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A cohort study was undertaken with a random sample of patients referred to our Plastic Surgery Skin Cancer Centre with BCC and SCC from January to June 2019 inclusive. Data collected included patient demographics, referral source, lesion duration (first appearance to treatment), histological data, excision margins and skin cancer risk, as defined by BAD guidelines.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In total, 728 patients were included [397 men, 331 women; median age 77\u2005years (interquartile range 72\u201385)] who underwent 872 excisions (BCC, n = 454; SCC, n = 418). Longer lesion duration was associated with increased BCC (P &amp;lt; 0.001 and P = 0.001, respectively) and SCC (P &amp;lt; 0.001 and P &amp;lt; 0.001, respectively) surface area and thickness on multivariable regression. The likelihood of developing very high risk histological parameters increased with SCC lesion time, including diameter &amp;gt; 40\u2005mm (P &amp;lt; 0.001), thickness &amp;gt; 6\u2005mm (P &amp;lt; 0.001) and total number of very high risk factors (P &amp;lt; 0.001). SCCs with lesion durations &amp;gt; 3\u2005months had greater median surface areas (706.9\u2005mm2 vs. 295.3\u2005mm2; P &amp;lt; 0.001) and thicknesses (3.5\u2005mm vs. 3\u2005mm; P &amp;lt; 0.001) than those of \u2264 3 months\u2019 duration; the same was found for median BCC surface area (263.9\u2005mm2 vs. 131.9\u2005mm2; P &amp;lt; 0.001). A general decline in the adequate excision of BCCs and SCCs was found with an increasing number of high- or very high risk parameters.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Longer lesion duration resulted in increased KSC thickness and surface area, and the increased presence of high risk factors as set out by the BAD. This was more common SCCs than for BCCs, and had a negative impact on surgical excision margins. Crucially, lesion duration was significantly associated with increased SCC (but not BCC) thickness at 3\u2005months. Our results support BAD guidance on the management of KSC, identifying the highest risk lesions and informing the practice of skin cancer units.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bjd\/ljaf097","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T19:08:07Z","timestamp":1741892887000},"page":"157-166","source":"Crossref","is-referenced-by-count":2,"title":["St Andrews Referral Delay in Skin Cancer (StARDISC): a study of keratinocyte skin cancer time to treatment, growth, invasiveness, British Association of Dermatologists risk factors and excision adequacy"],"prefix":"10.1093","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6403-546X","authenticated-orcid":false,"given":"Ben H","family":"Miranda","sequence":"first","affiliation":[{"name":"St Andrew\u2019s Centre for Plastic Surgery and Burns, Broomfield Hospital , Chelmsford ,","place":["UK"]},{"name":"St Andrew\u2019s Anglia Ruskin (StAAR) Research Group, School of Medicine, Faculty of Health, Education, Medicine and Social Care, Anglia Ruskin University , Chelmsford ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6313-2401","authenticated-orcid":false,"given":"Shahab","family":"Shahid","sequence":"additional","affiliation":[{"name":"St Andrew\u2019s Centre for Plastic Surgery and Burns, Broomfield Hospital , Chelmsford ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Corriero","sequence":"additional","affiliation":[{"name":"St Andrew\u2019s Centre for Plastic Surgery and Burns, Broomfield Hospital , Chelmsford ,","place":["UK"]},{"name":"St Andrew\u2019s Anglia Ruskin (StAAR) Research Group, School of Medicine, Faculty of Health, Education, Medicine and Social Care, Anglia Ruskin University , Chelmsford ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jufen","family":"Zhang","sequence":"additional","affiliation":[{"name":"St Andrew\u2019s Anglia Ruskin (StAAR) Research Group, School of Medicine, Faculty of Health, Education, Medicine and Social Care, Anglia Ruskin University , Chelmsford ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Kosasih","sequence":"additional","affiliation":[{"name":"St Andrew\u2019s Centre for Plastic Surgery and Burns, Broomfield Hospital , Chelmsford ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naguib","family":"El-Muttardi","sequence":"additional","affiliation":[{"name":"St Andrew\u2019s Centre for Plastic Surgery and Burns, Broomfield Hospital , Chelmsford ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"2025062507174438600_ljaf097-B1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/pubmed\/fdt032","article-title":"Measuring current and future cost of skin cancer in England","volume":"36","author":"Vallejo-Torres","year":"2014","journal-title":"J public health (Oxford)"},{"key":"2025062507174438600_ljaf097-B2","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1002\/ski2.61","article-title":"An updated report on the incidence and epidemiological trends of keratinocyte cancers in the United Kingdom 2013\u20132018","volume":"1","author":"Kwiatkowska","year":"2021","journal-title":"Skin Health Dis"},{"key":"2025062507174438600_ljaf097-B3"},{"key":"2025062507174438600_ljaf097-B4","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.bjps.2021.09.015","article-title":"A study of the effects of delayed patient presentation on cutaneous SCC progression","volume":"75","author":"Shahid","year":"2022","journal-title":"J\u00a0Plast Reconstr Aesthet Surg"},{"key":"2025062507174438600_ljaf097-B5","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1016\/j.bjps.2022.04.076","article-title":"A study of the effects of pre-operative cutaneous BCC duration on tumour progression","volume":"75","author":"Mavrokefalou","year":"2022","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"2025062507174438600_ljaf097-B6","first-page":"e598","article-title":"The effect of the COVID-19 pandemic on skin cancer surgery in the United Kingdom: a national, multi-centre, prospective cohort study and survey of Plastic Surgeons","volume":"107","author":"Nolan","year":"2020","journal-title":"Br J Surg"},{"key":"2025062507174438600_ljaf097-B7","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/bjd.19267","article-title":"Reduction in skin cancer diagnosis, and overall cancer referrals, during the COVID-19 pandemic","volume":"183","author":"Earnshaw","year":"2020","journal-title":"Br J Dermatol"},{"key":"2025062507174438600_ljaf097-B8","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jaad.2020.12.065","article-title":"The magnitude of COVID-19\u2019s effect on the timely management of melanoma and nonmelanoma skin cancers","volume":"84","author":"Marson","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"2025062507174438600_ljaf097-B9","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.bjps.2020.10.087","article-title":"Major fall in urgent skin cancer referrals during the COVID-19 outbreak","volume":"74","author":"Rich","year":"2021","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"2025062507174438600_ljaf097-B10","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jaad.2010.06.028","article-title":"Delayed treatment and continued growth of nonmelanoma skin cancer","volume":"64","author":"Alam","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"2025062507174438600_ljaf097-B11","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1524-4725.2009.01240.x","article-title":"Randomized comparison of Mohs micrographic surgery and surgical excision for small nodular basal cell carcinoma: tissue-sparing outcome","volume":"35","author":"Muller","year":"2009","journal-title":"Dermatol Surg"},{"key":"2025062507174438600_ljaf097-B12"},{"key":"2025062507174438600_ljaf097-B13","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1002\/cncr.32969","article-title":"Management of primary skin cancer during a pandemic: multidisciplinary recommendations","volume":"126","author":"Baumann","year":"2020","journal-title":"Cancer"},{"key":"2025062507174438600_ljaf097-B14","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.0022-202X.2004.23546.x","article-title":"Relationship of treatment delay with surgical defect size from keratinocyte carcinoma (basal cell carcinoma and squamous cell carcinoma of the skin)","volume":"124","author":"Eide","year":"2005","journal-title":"J Invest Dermatol"},{"key":"2025062507174438600_ljaf097-B15","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamadermatol.2015.4994","article-title":"Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: a systematic review and meta-analysis","volume":"152","author":"Thompson","year":"2016","journal-title":"JAMA Dermatol"},{"key":"2025062507174438600_ljaf097-B16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/bjd.19621","article-title":"British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020","volume":"184","author":"Keohane","year":"2021","journal-title":"Br J Dermatol"},{"key":"2025062507174438600_ljaf097-B17","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/bjd.20524","article-title":"British Association of Dermatologists guidelines for the management of adults with basal cell carcinoma 2021","volume":"185","author":"Nasr","year":"2021","journal-title":"Br J Dermatol"},{"key":"2025062507174438600_ljaf097-B18"},{"key":"2025062507174438600_ljaf097-B19"},{"key":"2025062507174438600_ljaf097-B20","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1470-2045(08)70178-5","article-title":"Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study","volume":"9","author":"Brantsch","year":"2008","journal-title":"Lancet Oncol"},{"key":"2025062507174438600_ljaf097-B21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/2000656X.2021.1883633","article-title":"St Andrew\u2019s COVID-19 Surgery Safety (StACS) study: skin cancer","volume":"55","author":"Miranda","year":"2021","journal-title":"J Plast Surg Hand Surg"},{"key":"2025062507174438600_ljaf097-B22","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jaad.2009.09.044","article-title":"Factors associated with large cutaneous squamous cell carcinomas","volume":"63","author":"Renzi","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"2025062507174438600_ljaf097-B23","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1046\/j.1365-2133.1999.03111.x","article-title":"Clinical measurement of dimensions of basal cell carcinoma: effect of waiting for elective surgery","volume":"141","author":"Kirkup","year":"1999","journal-title":"Br J Dermatol"},{"key":"2025062507174438600_ljaf097-B24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.15585\/mmwr.mm6912e2","article-title":"Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) \u2013 United States, February 12\u2013March 16, 2020","volume":"69","author":"CDC COVID-19 Response Team","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025062507174438600_ljaf097-B25","first-page":"305","article-title":"Non-metastatic non-melanoma skin cancers: our 3\u2005years of clinical experiences","volume":"6","author":"Sari","year":"2017","journal-title":"World J Plast Surg"},{"key":"2025062507174438600_ljaf097-B26","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/0190-9622(92)70144-5","article-title":"Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection","volume":"26","author":"Rowe","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"2025062507174438600_ljaf097-B27","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1200\/JCO.2005.02.155","article-title":"Mortality risk from squamous cell skin cancer","volume":"23","author":"Clayman","year":"2005","journal-title":"J Clin Oncol"},{"key":"2025062507174438600_ljaf097-B28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bjps.2023.02.001","article-title":"Close and incomplete excision margins in non-melanoma skin cancer: a tertiary plastic surgery center experience","volume":"79","author":"Mavrokefalou","year":"2023","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"2025062507174438600_ljaf097-B29","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1093\/bjs\/znac232","article-title":"National audit of non-melanoma skin cancer excisions performed by plastic surgery in the UK","volume":"109","author":"Nolan","year":"2022","journal-title":"Br J Surg"},{"key":"2025062507174438600_ljaf097-B30","first-page":"e9211","article-title":"Surgical margin of excision in basal cell carcinoma: a systematic review of literature","volume":"12","author":"Quazi","year":"2020","journal-title":"Cureus"},{"key":"2025062507174438600_ljaf097-B31","first-page":"37","article-title":"A review of the global guidelines on surgical margins for nonmelanoma skin cancers","volume":"10","author":"Nahhas","year":"2017","journal-title":"J\u00a0Clin Aesthet Dermatol"},{"key":"2025062507174438600_ljaf097-B32","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.bjps.2019.06.002","article-title":"A retrospective study of 694 basal cell carcinoma excisions to quantify deep margin documentation and clearance compared to histological type and surgical margin","volume":"72","author":"Kiely","year":"2019","journal-title":"J\u00a0Plast Reconstr Aesthet Surg"},{"key":"2025062507174438600_ljaf097-B33","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4103\/0019-5154.143514","article-title":"Margins in skin excision biopsies: principles and guidelines","volume":"59","author":"Ranjan","year":"2014","journal-title":"Indian J Dermatol"},{"key":"2025062507174438600_ljaf097-B34","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1093\/bjd\/ljad033","article-title":"\u2018Get Data Out\u2019 Skin: national cancer registry incidence and survival rates for all registered skin tumour groups for","volume":"188","author":"van Bodegraven","year":"2023","journal-title":"Br J Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljaf097\/62403037\/ljaf097.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/193\/1\/157\/62403037\/ljaf097.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/193\/1\/157\/62403037\/ljaf097.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T11:17:50Z","timestamp":1750850270000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/193\/1\/157\/8075159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,3,13]]},"published-print":{"date-parts":[[2025,6,20]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljaf097","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,3,13]]}}}